ID   SLAF6_MOUSE             Reviewed;         351 AA.
AC   Q9ET39; C6ESQ1; Q9ET40;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   07-APR-2021, entry version 158.
DE   RecName: Full=SLAM family member 6;
DE   AltName: Full=Lymphocyte antigen 108;
DE   AltName: CD_antigen=CD352;
DE   Flags: Precursor;
GN   Name=Slamf6; Synonyms=Ly108;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Spleen;
RX   PubMed=11132158; DOI=10.1007/s002510000252;
RA   Peck S.R., Ruley H.E.;
RT   "Ly108: a new member of the mouse CD2 family of cell surface proteins.";
RL   Immunogenetics 52:63-72(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, ALTERNATIVE SPLICING,
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS.
RX   PubMed=21422172; DOI=10.1084/jem.20101653;
RA   Keszei M., Detre C., Rietdijk S.T., Munoz P., Romero X., Berger S.B.,
RA   Calpe S., Liao G., Castro W., Julien A., Wu Y.Y., Shin D.M., Sancho J.,
RA   Zubiaur M., Morse H.C. III, Morel L., Engel P., Wang N., Terhorst C.;
RT   "A novel isoform of the Ly108 gene ameliorates murine lupus.";
RL   J. Exp. Med. 208:811-822(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=18031695; DOI=10.1016/j.immuni.2007.08.020;
RA   Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G.,
RA   Mamchak A.A., Terhorst C., Bendelac A.;
RT   "Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT
RT   cell lineage development.";
RL   Immunity 27:751-762(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=19648922; DOI=10.1038/ni.1763;
RA   Dong Z., Cruz-Munoz M.E., Zhong M.C., Chen R., Latour S., Veillette A.;
RT   "Essential function for SAP family adaptors in the surveillance of
RT   hematopoietic cells by natural killer cells.";
RL   Nat. Immunol. 10:973-980(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   FUNCTION.
RX   PubMed=20153220; DOI=10.1016/j.immuni.2010.01.010;
RA   Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J.,
RA   Wakeland E.K., Germain R.N., Schwartzberg P.L.;
RT   "Optimal germinal center responses require a multistage T cell:B cell
RT   adhesion process involving integrins, SLAM-associated protein, and CD84.";
RL   Immunity 32:253-265(2010).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF TYR-295; TYR-319; TYR-335 AND TYR-349.
RX   PubMed=22683125; DOI=10.1016/j.immuni.2012.05.016;
RA   Kageyama R., Cannons J.L., Zhao F., Yusuf I., Lao C., Locci M.,
RA   Schwartzberg P.L., Crotty S.;
RT   "The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for
RT   T cell help to B cells and NKT cell development.";
RL   Immunity 36:986-1002(2012).
RN   [10]
RP   FUNCTION.
RX   PubMed=25926831; DOI=10.3389/fimmu.2015.00158;
RA   Wang N., Halibozek P.J., Yigit B., Zhao H., O'Keeffe M.S., Sage P.,
RA   Sharpe A., Terhorst C.;
RT   "Negative regulation of humoral immunity due to interplay between the
RT   SLAMF1, SLAMF5, and SLAMF6 receptors.";
RL   Front. Immunol. 6:158-158(2015).
RN   [11]
RP   FUNCTION.
RX   PubMed=25801429; DOI=10.4049/jimmunol.1403023;
RA   Wong E.B., Soni C., Chan A.Y., Domeier P.P., Shwetank V., Abraham T.,
RA   Limaye N., Khan T.N., Elias M.J., Chodisetti S.B., Wakeland E.K.,
RA   Rahman Z.S.;
RT   "B cell-intrinsic CD84 and Ly108 maintain germinal center B cell
RT   tolerance.";
RL   J. Immunol. 194:4130-4143(2015).
CC   -!- FUNCTION: Self-ligand receptor of the signaling lymphocytic activation
CC       molecule (SLAM) family. SLAM receptors triggered by homo- or
CC       heterotypic cell-cell interactions are modulating the activation and
CC       differentiation of a wide variety of immune cells and thus are involved
CC       in the regulation and interconnection of both innate and adaptive
CC       immune response. Activities are controlled by presence or absence of
CC       small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2
CC       (PubMed:19648922). Triggers cytolytic activity only in natural killer
CC       cells (NK) expressing high surface densities of natural cytotoxicity
CC       receptors (By similarity). Positive signaling in NK cells implicates
CC       phosphorylation of VAV1. NK cell activation seems to depend on SH2D1B
CC       and not on SH2D1A (By similarity). In conjunction with SLAMF1 controls
CC       the transition between positive selection and the subsequent expansion
CC       and differentiation of the thymocytic natural killer T (NKT) cell
CC       lineage (PubMed:18031695). Promotes T cell differentiation into a
CC       helper T-cell Th17 phenotype leading to increased IL-17 secretion; the
CC       costimulatory activity requires SH2D1A (By similarity). Promotes
CC       recruitment of RORC to the IL-17 promoter (By similarity). In
CC       conjunction with SLAMF1 and CD84/SLAMF5 may be a negative regulator of
CC       the humoral immune response (PubMed:25926831). In the absence of
CC       SH2D1A/SAP can transmit negative signals to CD4(+) T-cells and NKT
CC       cells. Negatively regulates germinal center formation by inhibiting T-
CC       cell:B-cell adhesion; the function probably implicates increased
CC       association with PTPN6/SHP-1 via ITSMs in absence of SH2D1A/SAP
CC       (PubMed:22683125). However, reported to mediated T-cell adhesion, to
CC       participate in stable T-cell:B-cell interactions and to be involved in
CC       maintaining B-cell tolerance in germinal centers and in preventing
CC       autoimmunity (PubMed:20153220, PubMed:25801429). Involved in regulation
CC       of autoimmunity. Isoform 3 may be suppressor of pathogenic T-cell
CC       proliferation (PubMed:21422172). {ECO:0000250|UniProtKB:Q96DU3,
CC       ECO:0000269|PubMed:18031695, ECO:0000269|PubMed:19648922,
CC       ECO:0000269|PubMed:20153220, ECO:0000269|PubMed:21422172,
CC       ECO:0000269|PubMed:22683125, ECO:0000269|PubMed:25801429}.
CC   -!- SUBUNIT: Homodimer. Interacts with PTN6 and, upon phosphorylation, with
CC       PTN11 and SH2D1A/SAP (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Ly108s;
CC         IsoId=Q9ET39-1; Sequence=Displayed;
CC       Name=2; Synonyms=Ly108l;
CC         IsoId=Q9ET39-2; Sequence=VSP_010404, VSP_010405;
CC       Name=3; Synonyms=Ly108-H1;
CC         IsoId=Q9ET39-3; Sequence=VSP_058034;
CC   -!- TISSUE SPECIFICITY: Expressed on hematopoietic cells. Isoform 3 is
CC       expressed in thymocytes and B lymphocytes of C57Bl/6 strain.
CC       {ECO:0000269|PubMed:21422172}.
CC   -!- DOMAIN: The ITSMs (immunoreceptor tyrosine-based switch motifs) with
CC       the consensus sequence T-X-Y-X-X-[VI] present in SLAM family receptors
CC       have overlapping specificity for activating and inhibitory SH2 domain-
CC       containing binding partners. Especially they mediate the interaction
CC       with the SH2 domain of SH2D1A and SH2D1B. A 'two-out-of-three-pronged'
CC       mechanism is proposed involving threonine (position -2), phosphorylated
CC       tyrosine (position 0) and valine/isoleucine (position +3).
CC       {ECO:0000250|UniProtKB:Q13291}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Isoform 3 ameliorates spontaneous development in a
CC       systemic lupus erythematosus transfer model.
CC       {ECO:0000269|PubMed:21422172}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Found in Slamf-haplotype 1 mice such as
CC       C557Bl/6 but not in Slamf-haplotype 2 strains including 129, Balb/c and
CC       NOD. {ECO:0000269|PubMed:21422172}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF248635; AAG01737.1; -; mRNA.
DR   EMBL; AF248636; AAG01738.1; -; mRNA.
DR   EMBL; EU591721; ACF05482.1; -; mRNA.
DR   EMBL; AC091523; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030031; AAH30031.1; -; mRNA.
DR   CCDS; CCDS15504.1; -. [Q9ET39-2]
DR   CCDS; CCDS83638.1; -. [Q9ET39-1]
DR   CCDS; CCDS83639.1; -. [Q9ET39-3]
DR   RefSeq; NP_001334115.1; NM_001347186.1. [Q9ET39-1]
DR   RefSeq; NP_001334116.1; NM_001347187.1. [Q9ET39-3]
DR   RefSeq; NP_109635.1; NM_030710.2. [Q9ET39-2]
DR   SMR; Q9ET39; -.
DR   STRING; 10090.ENSMUSP00000130610; -.
DR   TCDB; 8.A.23.1.32; the basigin (basigin) family.
DR   GlyGen; Q9ET39; 9 sites.
DR   iPTMnet; Q9ET39; -.
DR   PhosphoSitePlus; Q9ET39; -.
DR   EPD; Q9ET39; -.
DR   PaxDb; Q9ET39; -.
DR   PRIDE; Q9ET39; -.
DR   ProteomicsDB; 261409; -. [Q9ET39-1]
DR   ProteomicsDB; 261410; -. [Q9ET39-2]
DR   ProteomicsDB; 261411; -. [Q9ET39-3]
DR   ABCD; Q9ET39; 3 sequenced antibodies.
DR   Antibodypedia; 34279; 480 antibodies.
DR   Ensembl; ENSMUST00000171330; ENSMUSP00000130610; ENSMUSG00000015314. [Q9ET39-2]
DR   Ensembl; ENSMUST00000194561; ENSMUSP00000141944; ENSMUSG00000015314. [Q9ET39-3]
DR   Ensembl; ENSMUST00000195656; ENSMUSP00000141448; ENSMUSG00000015314. [Q9ET39-1]
DR   GeneID; 30925; -.
DR   KEGG; mmu:30925; -.
DR   UCSC; uc007dph.1; mouse. [Q9ET39-1]
DR   UCSC; uc011wwh.1; mouse.
DR   CTD; 114836; -.
DR   MGI; MGI:1353620; Slamf6.
DR   eggNOG; ENOG502SSRG; Eukaryota.
DR   GeneTree; ENSGT00990000203668; -.
DR   HOGENOM; CLU_069386_2_0_1; -.
DR   InParanoid; Q9ET39; -.
DR   OMA; VFCLGPG; -.
DR   OrthoDB; 990343at2759; -.
DR   PhylomeDB; Q9ET39; -.
DR   TreeFam; TF334964; -.
DR   Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   BioGRID-ORCS; 30925; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; Slamf6; mouse.
DR   PRO; PR:Q9ET39; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q9ET39; protein.
DR   Bgee; ENSMUSG00000015314; Expressed in thymus and 75 other tissues.
DR   Genevisible; Q9ET39; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0001779; P:natural killer cell differentiation; IMP:UniProtKB.
DR   GO; GO:0001787; P:natural killer cell proliferation; IMP:UniProtKB.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; ISO:MGI.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISO:MGI.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; ISO:MGI.
DR   GO; GO:0072540; P:T-helper 17 cell lineage commitment; ISO:MGI.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunity; Immunoglobulin domain; Innate immunity; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..351
FT                   /note="SLAM family member 6"
FT                   /id="PRO_0000014962"
FT   TOPO_DOM        31..239
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        240..262
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        263..351
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          36..130
FT                   /note="Ig-like V-type"
FT   DOMAIN          147..210
FT                   /note="Ig-like C2-type"
FT   MOTIF           293..298
FT                   /note="ITSM 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13291"
FT   MOTIF           317..322
FT                   /note="ITSM 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q13291"
FT   MOD_RES         319
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96DU3"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        152
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        159
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        193
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        218
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        162..229
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        168..210
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         305..328
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:21422172"
FT                   /id="VSP_058034"
FT   VAR_SEQ         328..331
FT                   /note="ETVA -> AEYS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11132158"
FT                   /id="VSP_010404"
FT   VAR_SEQ         332..351
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11132158"
FT                   /id="VSP_010405"
FT   MUTAGEN         295
FT                   /note="Y->F: Decreases inhibitory signaling in germinal
FT                   center formation (absence of SH2D1A/SAP); when associated
FT                   with F-319 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         295
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   335 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         319
FT                   /note="Y->F: Decreases inhibitory signaling in germinal
FT                   center formation (absence of SH2D1A/SAP); when associated
FT                   with F-295 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         319
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   335 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         335
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   295 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         335
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   319 and F-349."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         349
FT                   /note="Y->F: Decreases inhibitory signaling in germinal
FT                   center formation (absence of SH2D1A/SAP); when associated
FT                   with F-295 and F-319."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         349
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   295 and F-335."
FT                   /evidence="ECO:0000269|PubMed:22683125"
FT   MUTAGEN         349
FT                   /note="Y->F: Strong inhibitory signaling in germinal center
FT                   formation (absence of SH2D1A/SAP); when associated with F-
FT                   319 and F-335."
FT                   /evidence="ECO:0000269|PubMed:22683125"
SQ   SEQUENCE   351 AA;  38638 MW;  A8DD9EBF650FB431 CRC64;
     MAVSRAPAPD SACQRMVWLF PLVFCLGSGS EVSQSSSDPQ LMNGVLGESA VLPLKLPAGK
     IANIIIWNYE WEASQVTALV INLSNPESPQ IMNTDVKKRL NITQSYSLQI SNLTMADTGS
     YTAQITTKDS EVITFKYILR VFERLGNLET TNYTLLLENG TCQIHLACVL KNQSQTVSVE
     WQATGNISLG GPNVTIFWDP RNSGDQTYVC RAKNAVSNLS VSVSTQSLCK GVLTNPPWNA
     VWFMTTISII SAVILIFVCW SIHVWKRRGS LPLTSQHPES SQSTDGPGSP GNTVYAQVTR
     PMQEMKIPKP IKNDSMTIYS IVNHSREETV ALTGYNQPIT LKVNTLINYN S
//
